Pharma & Biotech

Investor confidence in Danish pharmaceutical giant Novo Nordisk took a substantial hit this week following disappointing clinical trial results and...

Bruker Corporation is capturing investor attention with a powerful combination of strategic acquisition activity and impressive quarterly earnings. Shareholders have...

Pharmaceutical giant Bristol-Myers Squibb finds itself navigating contrasting currents as recent European regulatory approvals clash with a significant clinical trial...

Assembly Biosciences has captured significant market attention following a substantial price advance in recent weeks. The biotech firm's equity is...

Redcare Pharmacy finds itself grappling with a severe crisis of confidence among investors. The company's stock has shed more than...

Investor optimism for a breakthrough Alzheimer's treatment from Novo Nordisk has evaporated following disappointing clinical trial results. The pharmaceutical giant's...

Investor attention is sharply focused on today's CureVac shareholder meeting, which represents a critical juncture for BioNTech. The assembly will...

Investors in InnoCan Pharma faced a brutal trading session on Monday as the company's stock plummeted approximately 16% during European...

A coordinated assault by international hedge funds is placing significant downward pressure on Redcare Pharmacy stock. These financial firms have...

The future of Tübingen-based biotech firm CureVac hangs in the balance as the company approaches a critical juncture. With operational...